Centro Nacional de Investigaciones Científicas

The Centro Nacional de Investigaciones Científicas (CNIC) is a premier Cuban scientific institution dedicated to the research, development, and production of biotechnological and pharmaceutical products. Founded in 1965, it serves as a cornerstone of Cuba's life sciences sector and operates as part of the BioCubaFarma state business group. CNIC is globally recognized for its expertise in natural products, most notably developing Policosanol (PPG) for cholesterol management and Abexol for gastrointestinal health. The center integrates multidisciplinary research in biomedicine and chemistry with industrial-scale manufacturing capabilities. Its portfolio includes a range of therapeutic agents, nutritional supplements, and rapid diagnostic systems for microbiology. CNIC continues to engage in international collaborations to commercialize its proprietary innovations in global markets.